Psychiatry and Neurology, Neurology · Chicago, IL
NPI
1629335450
Since 2012
Specialty
Psychiatry and Neurology, Neurology
Code 2084N0400X
Group practices
3
Medicare group memberships
Hospitals
2
Hospital affiliations
1725 W Harrison St Ste 1106
Chicago, IL, 60612
Phone (312) 942-4500
Groups this clinician bills Medicare through
Medicare paid, 2024
$35K
2,894 services
Medicare patients, 2024
150
Average age 63
Drug cost, 2024
$2.5M
1,841 prescriptions
Company payments, 2025
$47K
From 7 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Thomas J Shoemaker was code 99215 (office e&m - established), 51 times for 45 patients. In total Thomas J Shoemaker billed 2,894 services in 18 codes, and Medicare paid $35K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2018-08-06.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99215 Office E&M - Established | Facility | 51 | 45 | $96.18 | $4,905 |
| 99214 Office E&M - Established | Facility | 50 | 44 | $72.30 | $3,615 |
| 99222 Hospital E&M - Initial | Facility | 18 | 18 | $107.99 | $1,944 |
| 99213 Office E&M - Established | Facility | 13 | 13 | $50.13 | $652 |
By year: 2022 $16K for 179 services; 2023 $41K for 2,642 services; 2024 $35K for 2,894 services.
Medicare prescription drug claims, 2024
In 2024, the drug Thomas J Shoemaker prescribed most often to Medicare patients was Dalfampridine Er (Dalfampridine), with 303 prescriptions and refills. In total Thomas J Shoemaker wrote 1,841 Medicare prescriptions that cost $2.5M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Dalfampridine Er Dalfampridine | 303 | 333 | 42 | $126K |
| Baclofen Generic | 214 | 347 | 49 | $4,022 |
| Gabapentin Generic | 105 | 163 | 30 | $2,047 |
| Duloxetine Hcl Generic | 80 | 152 | 25 | $1,583 |
| Kesimpta Pen Ofatumumab | 73 | 73 | Under 11 | $673K |
| Pregabalin Generic | 67 | 90 | 16 | $2,762 |
| Oxcarbazepine Generic | 52 | 94 | 12 | $1,488 |
| Solifenacin Succinate Generic | 40 | 85 | 15 | $3,447 |
| Myrbetriq Mirabegron | 38 | 38 | Under 11 | $17K |
| Tizanidine Hcl Generic | 31 | 49 | Under 11 | $259 |
| Clonazepam Generic | 30 | 44 | Under 11 | $387 |
| Topiramate Generic | 30 | 57 | 12 | $255 |
| Tecfidera Dimethyl Fumarate | 29 | 29 | Under 11 | $250K |
| Dimethyl Fumarate Generic | 25 | 29 | Under 11 | $53K |
| Modafinil Generic | 25 | 31 | Under 11 | $961 |
Brand drugs: 309 claims; generic drugs: 1,532 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Thomas J Shoemaker $47K ($47K in general payments such as food, travel and fees) from 7 companies. The largest payer was EMD Serono, Inc. with $25K.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.